Novo Nordisk A/S, Blueprint Medicines, BlackRock, Welltower, Blackstone, Prologis, and Apollo Global Management are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings are expected to grow at an above-average rate compared to the overall market. These firms typically reinvest profits into expansion and innovation rather than paying out substantial dividends, leading to higher valuation multiples. Investors buy growth stocks primarily for capital appreciation, betting that future earnings will justify their premium prices. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NYSE NVO traded up $1.82 during trading on Friday, hitting $74.47. The company had a trading volume of 6,426,881 shares, compared to its average volume of 6,869,762. The firm has a market capitalization of $334.19 billion, a P/E ratio of 22.62, a price-to-earnings-growth ratio of 0.90 and a beta of 0.66. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15. The stock has a 50 day simple moving average of $65.73 and a 200 day simple moving average of $80.90. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.74.
Read Our Latest Research Report on NVO
Blueprint Medicines (BPMC)
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.
Blueprint Medicines stock traded up $0.05 during mid-day trading on Friday, hitting $127.95. The stock had a trading volume of 1,929,529 shares, compared to its average volume of 1,710,827. Blueprint Medicines has a one year low of $73.04 and a one year high of $128.24. The company has a current ratio of 2.85, a quick ratio of 2.80 and a debt-to-equity ratio of 1.15. The firm has a market capitalization of $8.26 billion, a P/E ratio of -118.46 and a beta of 0.83. The firm's 50 day moving average is $94.75 and its 200 day moving average is $95.65.
Read Our Latest Research Report on BPMC
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
BLK traded up $5.76 during trading on Friday, reaching $991.22. 150,690 shares of the company traded hands, compared to its average volume of 686,577. The company has a market cap of $153.57 billion, a P/E ratio of 23.62, a PEG ratio of 1.90 and a beta of 1.41. The firm has a fifty day simple moving average of $924.37 and a 200 day simple moving average of $973.80. BlackRock has a 12-month low of $752.30 and a 12-month high of $1,084.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 5.23 and a current ratio of 5.23.
Read Our Latest Research Report on BLK
Welltower (WELL)
Welltower Inc. NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Shares of WELL traded up $0.46 during mid-day trading on Friday, hitting $153.49. 940,217 shares of the stock were exchanged, compared to its average volume of 2,908,918. The firm has a 50-day moving average of $148.03 and a two-hundred day moving average of $141.72. Welltower has a 52-week low of $100.13 and a 52-week high of $158.55. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.22 and a current ratio of 4.22. The company has a market cap of $100.38 billion, a PE ratio of 98.29, a price-to-earnings-growth ratio of 2.87 and a beta of 0.94.
Read Our Latest Research Report on WELL
Blackstone (BX)
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
Shares of NYSE:BX traded up $2.29 during trading on Friday, hitting $140.05. The company had a trading volume of 968,494 shares, compared to its average volume of 3,780,388. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.71. Blackstone has a one year low of $115.66 and a one year high of $200.96. The stock has a market cap of $102.19 billion, a price-to-earnings ratio of 38.52, a price-to-earnings-growth ratio of 1.07 and a beta of 1.67. The company has a fifty day simple moving average of $135.52 and a two-hundred day simple moving average of $157.96.
Read Our Latest Research Report on BX
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
PLD traded up $0.62 during trading hours on Friday, reaching $108.44. 1,202,037 shares of the company's stock traded hands, compared to its average volume of 4,140,618. The firm has a market capitalization of $100.62 billion, a PE ratio of 27.09, a PEG ratio of 2.70 and a beta of 1.25. Prologis has a 52-week low of $85.35 and a 52-week high of $132.57. The firm has a 50-day moving average price of $103.73 and a 200 day moving average price of $110.46. The company has a quick ratio of 0.43, a current ratio of 0.75 and a debt-to-equity ratio of 0.53.
Read Our Latest Research Report on PLD
Apollo Global Management (APO)
Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.
APO stock traded up $2.44 during mid-day trading on Friday, reaching $132.72. The company had a trading volume of 897,164 shares, compared to its average volume of 3,932,381. The company has a market capitalization of $75.85 billion, a PE ratio of 18.14, a price-to-earnings-growth ratio of 1.17 and a beta of 1.59. The firm has a 50 day moving average of $130.75 and a 200 day moving average of $150.14. Apollo Global Management has a 12 month low of $95.11 and a 12 month high of $189.49. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.44 and a quick ratio of 1.44.
Read Our Latest Research Report on APO
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novo Nordisk A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.
While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
